Brain and behavior · 2025
Study of the NOTCH3 Gene Reveals the First CADASIL Cases in Crete and a Novel Pathogenic Variant.
СтатьяКлинический случайНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Zaganas Ioannis, Tsiverdis Ioannis, Kokosali Evgenia, Litso Ionela, Drakos Minas, Skoula Irene, Zabetakis Alexandros, Mathioudakis Lambros, Mastorodemos Vassilios, Mitsias Panayiotis
Аннотация
BACKGROUND: NOTCH3 gene variants are associated with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). In this study we aimed to examine the presence of pathogenic NOTCH3 variants in individuals with suspected CADASIL on the Greek island of Crete. This represents the first report of CADASIL patients in Crete.
METHODS: We reviewed the medical records of the University Hospital of Heraklion and identified three patients with the clinical diagnosis of CADASIL. In these patients pathogenic NOTCH3 variants were identified through targeted or whole-exome sequencing (WES).
RESULTS: A novel heterozygous variant in exon 4 of the NOTCH3 gene (p.Cys206Trp; NM_000435.3:c.618C>G) was found in a 67-year-old woman who suffered from recurrent ischemic strokes, cognitive impairment, depression, and headache, as well as her son, who presented with headache, anxiety disorder, and insomnia. Brain MRI for both patients revealed white matter disease, including the anterior temporal lobes. The characteristics of this variant (a Cys-related variant in the epidermal growth factor repeats area) support its pathogenicity. We also identified a 72-year-old patient affected by CADASIL and carrying a previously described p.Arg607Cys (NM_000435.3:c.1819C>T) NOTCH3 variant.
CONCLUSIONS: This report extends the geographic and genotypic spectrum of pathogenic NOTCH3 variants and documents the first CADASIL cases on the island of Crete, Greece.
METHODS: We reviewed the medical records of the University Hospital of Heraklion and identified three patients with the clinical diagnosis of CADASIL. In these patients pathogenic NOTCH3 variants were identified through targeted or whole-exome sequencing (WES).
RESULTS: A novel heterozygous variant in exon 4 of the NOTCH3 gene (p.Cys206Trp; NM_000435.3:c.618C>G) was found in a 67-year-old woman who suffered from recurrent ischemic strokes, cognitive impairment, depression, and headache, as well as her son, who presented with headache, anxiety disorder, and insomnia. Brain MRI for both patients revealed white matter disease, including the anterior temporal lobes. The characteristics of this variant (a Cys-related variant in the epidermal growth factor repeats area) support its pathogenicity. We also identified a 72-year-old patient affected by CADASIL and carrying a previously described p.Arg607Cys (NM_000435.3:c.1819C>T) NOTCH3 variant.
CONCLUSIONS: This report extends the geographic and genotypic spectrum of pathogenic NOTCH3 variants and documents the first CADASIL cases on the island of Crete, Greece.